Show Summary Details
Page of

Pharmacotherapy for Autism Spectrum Disorders 

Pharmacotherapy for Autism Spectrum Disorders
Pharmacotherapy for Autism Spectrum Disorders

James T. McCracken

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 July 2020

Children, adolescents, and adults with the full range of the autism spectrum disorders (ASDs) are frequently referred for possible pharmacologic treatment for an array of associated difficult-to-manage behaviors, and to support adaptation and progress from other forms of interventions. This chapter reviews the available evidence for each of the major drug classes, as well as information regarding their safety and optimal use. It discusses current recommendations based on the best evidence available for the largest and most commonly presented targets for treatment in individuals with ASDs. Finally, it describes future directions for drug development in ASDs based on emerging models of etio-pathophysiology of ASDs and related conditions.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.